Our study focused on targeting the CBP/β-catenin interaction and provides evidence that inhibition of this signaling axis by PRI-724 modulates the invasive potential of melanoma cells and effectively induces apoptosis in time- and concentration-dependent manners. The gene discussed is CREBBP; the disease is melanoma.